SEC Form 4 · accession 0001179110-15-006748
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn F Tilton
Director
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Apr 24, 2015 | A | 2,793 | $0.00 | A | 28,631 | D | |
| Common shares without par valueF2 | holding | — | — | — | 350 | I | By Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
- F2The reporting person disclaims beneficial ownership of all securities held by his spouse.